FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Baxter recalls 300K flu vaccines

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


Baxter International ($BAX) has issued a voluntary recall of 300,000 doses of its popular flu vaccine Preflucel after a higher-than-expected number of side effects were reported in those who got the vaccine. The side effects were the type usually associated with flu vaccines, such as fatigue, muscle pain and headache. Most of the vaccines were distributed in Ireland and Scotland. Preflucel is a low-egg-content vaccine designed for those who are allergic to eggs, which are used to produce vaccines. 

"The vaccine should no longer be used and any remaining stock [of the recalled batches] should be returned to the original supplier for credit. No further Preflucel of any batch should be administered at this time," according to a listing on the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) website. Baxter stressed the the recall was precautionary and that those who have already received the shot don't need to be re-vaccinated.

- here's the listing
- check out this article for more

Related Articles:
Baxter issues precautionary recall of flu vaccine
Baxter's Preflucel gets EU OK

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about flu vaccine   Baxter International   vaccine recall   Preflucel